chr15	63623587	63623588	rs11630290	Iris characteristics	chr15	63623497	63623997	501	*	6.94	7.79	4.63	3.15	7.51e-07	3.01e-06
chr11	47272248	47272249	rs10501320	Proinsulin levels	chr11	47271926	47272426	501	*	6.66	7.19	5.8	1.4	0.00427	0.00856
chr10	18439030	18439031	rs12258967	Blood pressure	chr10	18438317	18439099	783	*	9.83	10.56	8.32	2.23	3.46e-08	1.87e-07
chr4	80243569	80243570	rs1458038	Blood pressure	chr4	80243452	80243952	501	*	10.14	10.72	9.15	1.58	2.06e-05	6.23e-05
chr8	17348068	17348069	rs4921542	Creutzfeldt-Jakob disease (variant)	chr8	17347635	17348135	501	*	6.7	7.53	4.54	2.99	4.94e-09	3.27e-08
chr2	60937196	60937197	rs13017599	Psoriatic arthritis	chr2	60936770	60937270	501	*	6.99	7.55	6.05	1.5	0.00233	0.00491
chr2	177044867	177044868	rs1529093	Non-alcoholic fatty liver disease histology (other)	chr2	177044539	177045039	501	*	9.52	10.18	8.27	1.91	8.1e-05	0.000219
chr13	78976799	78976800	rs7319358	Ulcerative colitis	chr13	78976634	78977134	501	*	8.51	9.44	5.24	4.2	9.55e-16	3.37e-14
chr6	51801833	51801834	rs10498792	Prostate cancer	chr6	51801351	51801851	501	*	7.28	8.14	4.85	3.29	5.21e-05	0.000146
chr6	88403098	88403099	rs10485165	Select biomarker traits	chr6	88402770	88403270	501	*	7.47	8.22	5.78	2.44	4.53e-05	0.000129
chr8	54524964	54524965	rs9298506	Intracranial aneurysm	chr8	54524963	54525463	501	*	6.44	7.32	3.81	3.51	6.38e-06	2.12e-05
chr6	34227234	34227235	rs1776897	Height	chr6	34226802	34227302	501	*	5.55	6.35	3.66	2.69	1.22e-05	3.84e-05
chr12	20368720	20368721	rs10841496	Male infertility	chr12	20367984	20368722	739	*	9.03	9.82	7.19	2.62	5.93e-10	4.91e-09
chr7	87231997	87231998	rs6942407	Food allergy	chr7	87231674	87232174	501	*	8.02	8.73	6.59	2.14	0.000697	0.00161
chr9	18362867	18362868	rs10511652	Myopia	chr9	18362789	18363289	501	*	8.66	9.16	7.91	1.25	0.0229	0.0395
chr14	79474040	79474041	rs7144011	Waist circumference	chr14	79473657	79474157	501	*	6.48	7.25	4.76	2.48	0.000143	0.000373
chr2	41954539	41954540	rs6740960	Nonsyndromic cleft lip with or without cleft palate	chr2	41954150	41954650	501	*	5.81	6.68	3.32	3.36	0.000163	0.000419
chr14	90698719	90698720	rs1742101	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	chr14	90698400	90698900	501	*	8.58	9.16	7.6	1.57	0.00946	0.0177
chr6	52528549	52528550	rs55828716	Intraocular pressure	chr6	52528392	52528892	501	*	7.55	8.15	6.48	1.67	0.00101	0.00226
chr7	32250953	32250954	rs17161076	Body mass index	chr7	32250711	32251211	501	*	7.37	8.12	5.7	2.41	2.44e-07	1.09e-06
chr10	112520943	112520944	rs12241008	Colorectal cancer	chr10	112520775	112521275	501	*	7.85	8.33	7.13	1.2	0.015	0.027
chr3	3799184	3799185	rs9827335	Rubella	chr3	3799174	3799674	501	*	9.91	10.29	9.41	0.88	0.0151	0.0271
chr18	31646245	31646246	rs1667284	Problematic alcohol use in trauma-exposed individuals	chr18	31645772	31646272	501	*	5.64	6.21	4.69	1.52	0.0148	0.0267
chr20	5970805	5970806	rs76498344	Menopause (age at onset)	chr20	5970333	5970833	501	*	7.23	7.78	6.33	1.44	0.00359	0.0073
chr3	43056273	43056274	rs3732858	Height	chr3	43055728	43056529	802	*	8.06	8.57	7.26	1.31	0.00414	0.00831
chr10	59708831	59708832	rs1171616	Serum metabolite concentrations in chronic kidney disease	chr10	59708694	59709194	501	*	6.73	7.37	5.53	1.85	0.00149	0.00324
chr6	82068785	82068786	rs9361886	Central corneal thickness	chr6	82068704	82069204	501	*	9.67	10.57	6.81	3.76	9.84e-14	2.11e-12
chrX	111759999	111760000	rs201820102	Rosacea symptom severity	chrX	111759636	111760136	501	*	8.25	9.14	5.47	3.67	8.05e-17	3.74e-15
chr8	19990569	19990570	rs17410962	Triglycerides	chr8	19990184	19990684	501	*	6.97	7.9	3.72	4.18	1.84e-07	8.38e-07
chr6	29966386	29966387	rs6935053	Ulcerative colitis	chr6	29965995	29966495	501	*	5.89	6.64	4.25	2.39	2.28e-05	6.84e-05
chr10	12389368	12389369	rs4451621	Educational attainment	chr10	12389311	12389811	501	*	9.17	9.72	8.28	1.44	0.00169	0.00364
chr11	19572259	19572260	rs11025185	Hepatitis	chr11	19571857	19572357	501	*	6.7	7.57	4.14	3.43	1.76e-10	1.66e-09
chr10	68232096	68232097	rs7916697	Optic disc area	chr10	68231912	68232412	501	*	7.32	8	5.97	2.04	9.38e-05	0.000252
chr10	119670121	119670122	rs2234962	Idiopathic dilated cardiomyopathy	chr10	119669868	119670710	843	*	7.88	8.5	6.73	1.77	0.000369	0.000893
chr2	179701951	179701952	rs16866933	Sudden cardiac arrest	chr2	179701649	179702149	501	*	7.79	8.65	5.27	3.38	3.45e-11	3.9e-10
chr17	45942346	45942347	rs242557	Progressive supranuclear palsy	chr17	45942153	45942653	501	*	7.75	8.34	6.73	1.61	0.00025	0.000622
chr11	20662494	20662495	rs2139424	Response to cytadine analogues (cytosine arabinoside)	chr11	20662123	20662623	501	*	7.16	7.9	5.53	2.37	0.00563	0.011
chr4	15352761	15352762	rs114133078	PR interval in Tripanosoma cruzi seropositivity	chr4	15352497	15352997	501	*	8.5	9.35	6.2	3.15	2.53e-13	4.9e-12
chr4	116954105	116954106	rs1440306	Bronchopulmonary dysplasia	chr4	116953925	116954425	501	*	7.81	8.73	4.61	4.12	8.2e-13	1.4e-11
chr6	142798695	142798696	rs12211360	Adiponectin levels	chr6	142798305	142798805	501	*	5.78	6.66	3.07	3.59	4.6e-08	2.41e-07
chr13	44128733	44128734	rs9525916	Homeostasis model assessment of insulin resistance (dietary factor interaction)	chr13	44128464	44128964	501	*	8.86	9.54	7.54	2	0.000507	0.0012
chr5	116204876	116204877	rs7709377	Metabolite levels  (X-11787)	chr5	116204671	116205171	501	*	6.04	6.95	3.05	3.9	3.88e-06	1.35e-05
chr13	80118676	80118677	rs8001641	Orofacial clefts	chr13	80118439	80118939	501	*	7.25	8.12	4.71	3.41	4.8e-08	2.5e-07
chr6	34227089	34227090	rs1759645	Height	chr6	34226802	34227302	501	*	5.55	6.35	3.66	2.69	1.22e-05	3.84e-05
chr7	37037249	37037250	rs10488031	QT interval	chr7	37037241	37037741	501	*	6.47	7.16	5.09	2.07	0.000201	0.000509
chr4	89757390	89757391	rs2736990	Parkinson's disease	chr4	89757302	89757802	501	*	6.77	7.54	5.02	2.51	0.000265	0.000657
chr4	15396282	15396283	rs1861046	Conduct disorder	chr4	15396125	15396625	501	*	5.56	6.11	4.68	1.43	0.0249	0.0427
chr11	33303830	33303831	rs16924133	Anger	chr11	33303472	33303972	501	*	5.36	6.13	3.62	2.5	0.000778	0.00178
chr11	118678873	118678874	rs507080	Serum metabolite levels	chr11	118678829	118679329	501	*	6.14	6.97	4.03	2.94	1.1e-07	5.26e-07
chr2	66532947	66532948	rs11678354	PR segment	chr2	66532932	66533432	501	*	6.77	7.6	4.55	3.05	2.95e-06	1.05e-05
chr15	95829400	95829401	rs744738	Obesity-related traits	chr15	95828994	95829494	501	*	5.94	6.8	3.5	3.31	4.26e-07	1.8e-06
chr4	89704960	89704961	rs356182	Parkinson's disease	chr4	89704561	89705061	501	*	6.69	7.48	4.76	2.72	0.000415	0.000996
chr14	70177452	70177453	rs7146198	Corneal curvature	chr14	70177027	70177527	501	*	6.73	7.4	5.43	1.98	0.0113	0.0208
chr8	60281611	60281612	rs10957125	Response to amphetamines	chr8	60281156	60281656	501	*	6.59	7.28	5.18	2.11	0.000169	0.000434
chr4	37936897	37936898	rs10010758	Periodontal microbiota	chr4	37936822	37937322	501	*	7.32	8.15	5.1	3.05	3.01e-10	2.69e-09
chr9	104826496	104826497	rs4149311	Myopia (pathological)	chr9	104826344	104826844	501	*	5.7	6.54	3.41	3.13	6.85e-06	2.27e-05
chr4	71261172	71261173	rs2579330	QT interval	chr4	71260900	71261400	501	*	6.4	7.22	4.32	2.9	7.21e-07	2.9e-06
chr17	55287427	55287428	rs7224610	Urate levels	chr17	55287215	55287715	501	*	5.97	6.68	4.48	2.2	0.000686	0.00158
chr1	247442297	247442298	rs10157379	Fibrinogen	chr1	247442092	247442592	501	*	5.36	6.14	3.58	2.56	0.000266	0.000659
chr20	11228874	11228875	rs6040449	Relative hand skill	chr20	11228534	11229034	501	*	9.7	10.53	7.53	3	3.73e-13	6.89e-12
chr8	105601093	105601094	rs17217757	Tuberculosis	chr8	105601022	105601522	501	*	8.96	9.8	6.75	3.05	2.49e-10	2.27e-09
chr2	86633508	86633509	rs114532231	Asymmetrical dimethylarginine levels	chr2	86633019	86633519	501	*	7.12	7.99	4.53	3.46	8.78e-10	6.99e-09
chr6	91135689	91135690	rs4424056	Amyotrophic lateral sclerosis (sporadic)	chr6	91135366	91135866	501	*	9.33	10.23	6.52	3.71	9.65e-15	2.62e-13
chr10	60167108	60167109	rs10509125	Behavioral disturbance or psychiatric symptoms and prion disease	chr10	60166999	60167499	501	*	5.63	6.22	4.59	1.63	0.0106	0.0197
chr20	49667096	49667097	rs17723576	Urate levels in obese individuals	chr20	49666830	49667330	501	*	5.76	6.37	4.69	1.68	0.0263	0.0448
chr20	59153293	59153294	rs259991	Attention function in attention deficit hyperactive disorder	chr20	59153228	59153728	501	*	6.44	7.03	5.41	1.62	0.0254	0.0435
chr18	51664274	51664275	rs1619249	Folding of antihelix	chr18	51664205	51664705	501	*	6.79	7.65	4.32	3.34	6.54e-08	3.31e-07
chr8	125470379	125470380	rs2954022	HDL cholesterol	chr8	125470172	125470672	501	*	6.69	7.63	3.05	4.58	7.45e-11	7.75e-10
chr18	37566243	37566244	rs150664883	3-hydroxypropylmercapturic acid levels in smokers	chr18	37565522	37566516	995	*	10.26	10.61	9.8	0.81	0.00762	0.0145
chr12	96098670	96098671	rs2540513	Small intestine neuroendocrine tumor	chr12	96098509	96099009	501	*	9.96	10.63	8.65	1.98	2.4e-06	8.7e-06
chr2	190679236	190679237	rs3771317	Primary biliary cholangitis	chr2	190678769	190679269	501	*	5.97	6.67	4.55	2.12	0.000139	0.000363
chr9	95462774	95462775	rs28377268	Bone mineral density (spine)	chr9	95462350	95462850	501	*	6.47	7.12	5.26	1.86	0.000355	0.000862
chr5	56521061	56521062	rs455660	Waist-to-hip ratio adjusted for body mass index	chr5	56520850	56521350	501	*	6.12	6.89	4.33	2.57	8.69e-05	0.000234
chr14	88218732	88218733	rs17124276	Survival in pancreatic cancer	chr14	88218484	88218984	501	*	7.53	8.45	4.47	3.98	1.01e-06	3.93e-06
chr1	184861124	184861125	rs34199165	Cough in response to angiotensin-converting enzyme inhibitor drugs	chr1	184860939	184861439	501	*	7.77	8.65	5.09	3.56	1.35e-12	2.17e-11
chr2	157922313	157922314	rs4130274	Severe gingival inflammation	chr2	157922281	157922781	501	*	7.26	8.2	3.74	4.46	1.23e-09	9.44e-09
chr8	60967385	60967386	rs142143628	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	chr8	60967175	60967994	820	*	9	9.86	6.58	3.28	3.6e-12	5.19e-11
chr3	146921799	146921800	rs200803778	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	chr3	146921644	146922144	501	*	7.07	7.99	3.93	4.06	6.15e-13	1.08e-11
chr7	142776454	142776455	rs149506335	Alcoholic chronic pancreatitis	chr7	142776153	142776653	501	*	9.64	10.32	8.27	2.05	1e-05	3.22e-05
chr10	30812814	30812815	rs1417569	Tuberculosis	chr10	30812419	30812919	501	*	6.49	7.32	4.26	3.07	1.56e-07	7.24e-07
chr5	34504277	34504278	rs6880621	Red blood cell count	chr5	34503894	34504394	501	*	9.63	10.46	7.45	3.01	4.91e-17	2.41e-15
chr11	33892021	33892022	rs2273799	Red blood cell count	chr11	33891603	33892103	501	*	6.07	6.86	4.13	2.74	9.39e-07	3.69e-06
chr5	52801055	52801056	rs1499280	Reticulocyte fraction of red cells	chr5	52800634	52801134	501	*	8.17	8.72	7.28	1.45	0.000959	0.00216
chr5	131535002	131535003	rs139737896	Perceived unattractiveness to mosquitoes	chr5	131534901	131535401	501	*	7.01	7.8	5.17	2.63	5.93e-05	0.000165
chr14	64973406	64973407	rs150546699	Itch intensity from mosquito bite adjusted by bite size	chr14	64973032	64973532	501	*	6.03	6.66	4.87	1.8	0.00612	0.0119
chr3	36482913	36482914	rs2290530	Itch intensity from mosquito bite adjusted by bite size	chr3	36482826	36483326	501	*	7.71	8.59	5.17	3.41	3.31e-14	7.98e-13
chr10	23310629	23310630	rs4748857	Systemic lupus erythematosus	chr10	23310373	23310873	501	*	7.66	8.54	4.91	3.63	1.87e-13	3.74e-12
chr15	68335825	68335826	rs2306022	Dupuytren's disease	chr15	68335661	68336161	501	*	5.12	5.71	4.1	1.61	0.0115	0.0212
chr1	197738021	197738022	rs59365945	Facial morphology (factor 4, facial height related to vertical position of gnathion)	chr1	197737892	197738392	501	*	7.5	8.38	4.9	3.48	1.35e-07	6.36e-07
chr8	38411996	38411997	rs13317	Nonsyndromic cleft lip with cleft palate	chr8	38411505	38412005	501	*	5.83	6.46	4.71	1.75	0.00431	0.00863
chr5	149217131	149217132	rs3839234	Lung function (FEV1)	chr5	149216980	149217480	501	*	8.99	9.9	5.85	4.05	4.18e-26	1.92e-23
chr2	143840863	143840864	rs1257344	Diisocyanate-induced asthma	chr2	143840529	143841029	501	*	5.34	6.19	2.98	3.21	3.08e-05	9.02e-05
chr14	72812712	72812713	rs4903064	Renal cell carcinoma	chr14	72812284	72812784	501	*	7.1	7.6	6.33	1.26	0.0116	0.0214
chr1	90781788	90781789	rs6669072	Cognitive function	chr1	90781580	90782496	917	*	7.38	7.88	6.59	1.29	0.00511	0.0101
chr12	132442096	132442097	rs10870468	Gait speed in old age	chr12	132441701	132442201	501	*	4.74	5.62	2.07	3.55	8.05e-06	2.63e-05
chr2	213046711	213046712	rs72948213	Facial morphology (factor 10, width of nasal floor)	chr2	213046352	213046852	501	*	6.93	7.84	3.84	4	2.1e-11	2.52e-10
chr2	106117609	106117610	rs17213078	Facial morphology (factor 23)	chr2	106117279	106117779	501	*	5.8	6.56	4.09	2.47	0.000203	0.000513
chr7	153748297	153748298	rs62486163	Facial morphology (factor 3, length of philtrum)	chr7	153747889	153748389	501	*	5.38	6.14	3.65	2.49	8.91e-05	0.00024
chr11	27726946	27726947	rs17309930	Childhood body mass index	chr11	27726901	27727401	501	*	8.41	9.24	6.2	3.04	4.59e-06	1.57e-05
chr20	62317060	62317061	rs2236521	Pelvic organ prolapse	chr20	62316853	62317353	501	*	5.85	6.61	4.14	2.47	1.67e-05	5.14e-05
chr16	79768943	79768944	rs4284656	Oropharynx cancer	chr16	79768586	79769086	501	*	5.59	6.23	4.39	1.84	0.00295	0.00609
chr14	90287967	90287968	rs11626933	Gut microbiota (bacterial taxa)	chr14	90287637	90288137	501	*	6.21	6.89	4.86	2.03	0.000118	0.000312
chr3	38247760	38247761	rs3925158	Gut microbiota (bacterial taxa)	chr3	38247304	38247804	501	*	7.12	7.93	5.08	2.85	8.19e-09	5.15e-08
chr14	77902942	77902943	rs74065827	Response to paliperidone in schizophrenia (positive Marder score)	chr14	77902736	77903236	501	*	7.25	8.03	5.41	2.62	1.52e-06	5.74e-06
chr5	31182306	31182307	rs6869294	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	chr5	31182113	31182831	719	*	8.78	9.51	7.22	2.3	1.02e-07	4.92e-07
chr6	79878444	79878445	rs6919854	Daytime sleep phenotypes	chr6	79878361	79878861	501	*	8.04	8.56	7.24	1.32	0.00157	0.00342
chr3	188169789	188169790	rs16863064	Schizophrenia	chr3	188169745	188170245	501	*	5.97	6.66	4.6	2.06	0.00622	0.0121
chr12	57094031	57094032	rs324017	Schizophrenia	chr12	57093804	57094304	501	*	5.62	6.44	3.49	2.95	2.61e-06	9.37e-06
chr14	92603644	92603645	rs72697297	Post bronchodilator FEV1/FVC ratio	chr14	92603488	92604212	725	*	7.05	7.58	6.21	1.37	0.00485	0.00961
chr7	80183510	80183511	rs67077197	Post bronchodilator FEV1	chr7	80183290	80183790	501	*	5.68	6.5	3.54	2.96	0.0014	0.00306
chr2	174772186	174772187	rs187076367	Post bronchodilator FEV1	chr2	174771526	174772345	820	*	7.47	7.99	6.66	1.33	0.0119	0.0218
chr4	140004716	140004717	rs1877075	Depression	chr4	140004477	140004977	501	*	6.29	6.94	5.1	1.84	0.00371	0.00751
chr18	37784134	37784135	rs12961969	Neuroticism	chr18	37783666	37784166	501	*	7.55	8.42	5.03	3.39	1.03e-11	1.33e-10
chr4	89836354	89836355	rs1372520	Neuroticism	chr4	89835971	89836471	501	*	7.31	8.07	5.63	2.44	0.000167	0.000428
chr6	21381296	21381297	rs6917586	Sum neutrophil eosinophil counts	chr6	21381280	21381780	501	*	9.25	9.78	8.41	1.37	0.0251	0.043
chr6	34651116	34651117	rs2814993	Height	chr6	34650756	34651256	501	*	5.42	6.2	3.62	2.58	0.000162	0.000418
chr11	116082456	116082457	rs77544685	Late-onset Alzheimer's disease	chr11	116082164	116082664	501	*	7.49	8.37	4.89	3.48	6.02e-11	6.42e-10
chr22	48492443	48492444	rs1034435	Late-onset Alzheimer's disease	chr22	48492293	48492793	501	*	5.48	6.05	4.54	1.51	0.0106	0.0197
chr9	107043881	107043882	rs138543081	Late-onset Alzheimer's disease	chr9	107043869	107044369	501	*	8.67	9.18	7.86	1.33	0.000334	0.000814
chr12	112261736	112261737	rs2285810	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	chr12	112261466	112261966	501	*	6.67	7.51	4.39	3.12	1.83e-09	1.35e-08
chr2	202015507	202015508	rs4675248	Educational attainment (years of education)	chr2	202015351	202015851	501	*	8.45	9.39	4.9	4.49	1.93e-21	2.76e-19
chr6	81753659	81753660	rs915125	Granulocyte percentage of myeloid white cells	chr6	81753165	81753665	501	*	8.95	9.44	8.2	1.24	0.0105	0.0195
chr1	90730619	90730620	rs12042107	Educational attainment	chr1	90730246	90730746	501	*	6.5	7.41	3.5	3.92	1.7e-10	1.61e-09
chr14	52042383	52042384	rs1982963	Waist-to-hip ratio adjusted for body mass index	chr14	52042332	52043073	742	*	6.87	7.71	4.57	3.15	8.83e-09	5.51e-08
chr7	36645539	36645540	rs7794780	Skin pigmentation	chr7	36645061	36645561	501	*	6.42	7.29	3.8	3.49	4.68e-10	4e-09
chr14	52060469	52060470	rs754423	Craniofacial microsomia	chr14	52060064	52060564	501	*	6.23	7.16	2.92	4.23	4.61e-09	3.08e-08
chr13	39160239	39160240	rs183751764	Fibroblast growth factor basic levels	chr13	39159945	39160445	501	*	8.18	9.06	5.43	3.63	2.18e-16	9.17e-15
chr11	108565591	108565592	rs74435620	Interleukin-1-receptor antagonist levels	chr11	108565581	108566081	501	*	7.45	8.1	6.25	1.85	7.97e-05	0.000216
chr12	102765873	102765874	rs190043735	Interleukin-1-receptor antagonist levels	chr12	102765762	102766262	501	*	7.18	8.11	3.78	4.33	0.00889	0.0167
chr11	123519517	123519518	rs12799226	Interleukin-2 receptor antagonist levels	chr11	123519036	123519536	501	*	8.83	9.28	8.17	1.11	0.00945	0.0177
chr2	197273746	197273747	rs116220125	Interleukin-18 levels	chr2	197273420	197273920	501	*	8.27	9.11	6.03	3.08	2.01e-13	4e-12
chr14	92603635	92603636	rs72697295	Post bronchodilator FEV1/FVC ratio	chr14	92603488	92604212	725	*	7.05	7.58	6.21	1.37	0.00485	0.00961
chr3	55091110	55091111	rs193058367	Post bronchodilator FEV1/FVC ratio	chr3	55090700	55091200	501	*	6.87	7.43	5.93	1.49	0.0189	0.0332
chr10	121138445	121138446	rs1907240	Body mass index	chr10	121138399	121138899	501	*	6.72	7.5	4.95	2.55	3.68e-06	1.28e-05
chr2	156342049	156342050	rs115182184	Major depression and alcohol dependence	chr2	156341618	156342118	501	*	8.06	8.69	6.92	1.77	0.00138	0.00303
chr15	85756967	85756968	rs62025270	Idiopathic pulmonary fibrosis	chr15	85756715	85757215	501	*	5.28	6.02	3.69	2.33	0.000197	0.000498
chr6	29723242	29723243	rs1362126	Colorectal cancer	chr6	29723105	29723605	501	*	5.93	6.51	4.97	1.54	0.023	0.0396
chr12	20445632	20445633	rs10841529	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	chr12	20445614	20446114	501	*	10.18	11.09	7.13	3.96	8.97e-24	2.22e-21
chr3	186413811	186413812	rs9853115	Intraocular pressure	chr3	186413471	186413971	501	*	7.31	7.88	6.35	1.53	0.00555	0.0109
chr13	80049211	80049212	rs7981942	Fasting blood insulin (BMI interaction)	chr13	80048731	80049231	501	*	8.87	9.58	7.42	2.15	4.54e-09	3.03e-08
chr11	133922749	133922750	rs34845616	Hand grip strength	chr11	133922419	133922919	501	*	5.65	6.45	3.73	2.72	5.1e-06	1.73e-05
chr6	31493934	31493935	rs2395040	Lobe attachment (rater-scored or self-reported)	chr6	31493716	31494216	501	*	5.57	6.48	2.47	4.01	3.94e-09	2.67e-08
chr6	56371028	56371029	rs6899968	Lobe attachment (rater-scored or self-reported)	chr6	56370538	56371293	756	*	8.56	9.26	7.12	2.15	0.000118	0.000311
chr4	47278539	47278540	rs13127214	Major depressive disorder	chr4	47278533	47279033	501	*	10.21	11.11	7.34	3.77	1.08e-20	1.31e-18
chr15	63985443	63985444	rs922182	Blood protein levels	chr15	63985095	63985595	501	*	9.05	9.95	6.24	3.7	4.08e-14	9.64e-13
chr5	96734501	96734502	rs149313	Blood protein levels	chr5	96734062	96734562	501	*	7.02	7.89	4.46	3.43	4.24e-10	3.65e-09
chr6	134047815	134047816	rs965652	Coronary artery disease	chr6	134047618	134048118	501	*	8.07	8.87	6.12	2.75	5.77e-07	2.38e-06
chr1	199274100	199274101	rs1325190	Rheumatoid arthritis	chr1	199274073	199274573	501	*	9.59	10.26	8.27	2	3.52e-06	1.23e-05
chr6	82068832	82068833	rs12526513	Intraocular pressure	chr6	82068704	82069204	501	*	9.67	10.57	6.81	3.76	9.84e-14	2.11e-12
chr7	134299375	134299376	rs2075371	Mean platelet volume	chr7	134298900	134299400	501	*	6.97	7.59	5.84	1.75	0.000597	0.00139
chr9	134056342	134056343	rs2157770	Mean platelet volume	chr9	134055888	134056388	501	*	6.58	7.2	5.46	1.75	0.00106	0.00237
chr12	49277876	49277877	rs80012730	Mean platelet volume	chr12	49277434	49277934	501	*	6.17	6.68	5.36	1.32	0.0192	0.0338
chr19	16086611	16086612	rs2303149	Mean platelet volume	chr19	16086466	16086966	501	*	6.37	7.13	4.7	2.43	0.000768	0.00176
chr6	31493781	31493782	rs3094006	Plateletcrit	chr6	31493716	31494216	501	*	5.57	6.48	2.47	4.01	3.94e-09	2.67e-08
chr3	2098694	2098695	rs13071423	Blood protein levels	chr3	2098392	2098892	501	*	9.48	9.94	8.79	1.16	0.00523	0.0103
chr14	52042345	52042346	rs17831525	Blood protein levels	chr14	52042332	52043073	742	*	6.87	7.71	4.57	3.15	8.83e-09	5.51e-08
chr1	56938892	56938893	rs3216676	Blood protein levels	chr1	56938589	56939089	501	*	6.54	7.26	5.04	2.22	6.13e-05	0.00017
chr1	56932065	56932066	rs612563	Blood protein levels	chr1	56931658	56932158	501	*	8.13	8.9	6.38	2.52	6.58e-05	0.000181
chr3	53843122	53843123	rs6445607	Blood protein levels	chr3	53842721	53843221	501	*	7.1	7.61	6.3	1.3	0.0104	0.0193
chr4	8556539	8556540	rs13116227	Systemic lupus erythematosus	chr4	8556243	8556743	501	*	5.38	6.24	2.99	3.25	3.88e-05	0.000112
chr8	128178298	128178299	rs12156002	Systemic lupus erythematosus	chr8	128178205	128178705	501	*	7.08	8	3.77	4.23	2.53e-12	3.79e-11
chr12	109822897	109822898	rs7971845	Creatinine levels	chr12	109822841	109823341	501	*	6.55	7.4	4.25	3.14	2.32e-07	1.04e-06
chr5	39424526	39424527	rs1818782	Aspartate aminotransferase levels	chr5	39424121	39424621	501	*	6.68	7.52	4.39	3.13	5.21e-08	2.69e-07
